Cargando…
Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort
This naturalistic study analysed the association between cumulative lifetime antipsychotic dose and cognition in schizophrenia after an average of 16.5 years of illness. Sixty participants with schizophrenia and 191 controls from the Northern Finland Birth Cohort 1966 were assessed at age 43 years w...
Autores principales: | Husa, Anja P., Moilanen, Jani, Murray, Graham K., Marttila, Riikka, Haapea, Marianne, Rannikko, Irina, Barnett, Jennifer H., Jones, Peter B., Isohanni, Matti, Remes, Anne M., Koponen, Hannu, Miettunen, Jouko, Jääskeläinen, Erika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier/North-Holland Biomedical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241225/ https://www.ncbi.nlm.nih.gov/pubmed/27888683 http://dx.doi.org/10.1016/j.psychres.2016.10.085 |
Ejemplares similares
-
S230. LONG-TERM ANTIPSYCHOTIC MEDICATION IN SCHIZOPHRENIA: BENEFITS, RISKS AND FOLLOW-UP: DATA FROM FINNISH COHORT STUDIES AND SYSTEMATIC REVIEW
por: Isohanni, Matti, et al.
Publicado: (2018) -
T78. LONG-TERM PROGNOSIS OF SCHIZOPHRENIA - RESULTS FROM THE NORTHERN FINLAND BIRTH COHORT 1966
por: Jääskeläinen, Erika, et al.
Publicado: (2018) -
Twenty Years of Schizophrenia Research in the Northern Finland Birth Cohort 1966: A Systematic Review
por: Jääskeläinen, Erika, et al.
Publicado: (2015) -
Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function
por: Guo, Joyce Y., et al.
Publicado: (2015) -
Poor premorbid school performance, but not severity of illness, predicts cognitive decline in schizophrenia in midlife
por: Rannikko, Irina, et al.
Publicado: (2015)